Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
- 1 September 2013
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 337 (2), 276-284
- https://doi.org/10.1016/j.canlet.2013.04.028
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiopoietins 1 and 2 and Tie‐2 receptor expression in human ductal breast diseaseHistopathology, 2011
- Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancerThe FASEB Journal, 2011
- Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor GrowthClinical Cancer Research, 2011
- Angiopoietin-2 Promotes Disease Progression of Neuroendocrine TumorsClinical Cancer Research, 2010
- Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosisEndocrine-Related Cancer, 2009
- Angiopoietin-2 Serum Levels Are Elevated in Patients With Liver Cirrhosis and Hepatocellular CarcinomaThe American Journal of Gastroenterology, 2007
- Angiopoietin: A TIE(d) Balance in Tumor AngiogenesisMolecular Cancer Research, 2007
- Angiopoietins in malignancyEuropean Journal of Surgical Oncology, 2007
- Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumorsJournal of the American College of Surgeons, 2004
- Biologic significance of angiopoietin-2 expression in human hepatocellular carcinomaJCI Insight, 1999